Study, year | Study type | Aneurysms (n) | Patients (n) | Complications (n) | Permanent | Complications (%) | Mortality (%) | Complication type (n) |
---|---|---|---|---|---|---|---|---|
Lylyk et al, 20099 | Retrospective | 63 | 53 | 6 (30-day periprocedural) | 0 | 11 | 0 | Access site (5), cranial neuropathy (3), rash (1) |
Szikora et al, 20107 | Retrospective | 19 | 18 | 4 | 2 | 22.2 | 5.5 | Ischemic (2), in-stent thrombosis (1), SAH (1) |
Chitale et al, 20128 | Retrospective | 42 | 36 | 5 (sx)/4 (asx) | N/A | 13.9 (sx), 11 (asx) | 2.8 | ICH (4); dissection (1); symptomatic CVA (2) |
Leung et al, 201218 | Systematic review | 448 | 414 | 46 | N/A | 6.3 | 1.5 | Aneurysm rupture (3), ischemic events (14), mass effect (6), access site (11), unknown cause of death (1) |
Pistocchi et al, 20124 | Retrospective | 30 | 26 | 3 | 1 | 11.1 | 0 | Access site (1), arterial perforation (1), CVA (1) |
Brinjikji et al, 20132 | Meta-analysis | 1654 | 1451 | N/A | 5 | 4 | Ischemic 6%; SAH 4%; IPH3% | |
Current study, 2014 | Retrospective | 137 | 126 | 40 | 4 | 31.7 | 2.4 | See box 1 |
asx, asymptomatic; CVA, cerebrovascular accident; ICH, intracranial hemorrhage; IPH, intraparenchymal hemorrhage; n, number; SAH, subarachnoid hemorrhage; sx, symptomatic.